Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML

NCT07437170 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Pediatric Acute Myeloid Leukemia
NUP98 Fusion-positive Acute Myeloid Leukemia

Interventions

DRUG: Selinexor
DRUG: ZJCH-AML Standardized Chemotherapy

Sponsor

The Children's Hospital of Zhejiang University School of Medicine

Collaborators

[object Object]